Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era |
| |
| Affiliation: | 1. Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut;2. Department of Student Affairs, Baylor College of Medicine, Houston, Texas;3. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas;4. Hepatology Program, Division of Abdominal Transplantation, Michael E DeBakey Department of General Surgery, Baylor College of Medicine, Houston, Texas;5. Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas;6. The Vatche and Tamar Manoukian Division of Digestive Diseases, University of California at Los Angeles, Los Angeles, California;7. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford, California;8. Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas |
| |
| Abstract: | |
| |
| Keywords: | Black/African-American Direct Acting Antiviral Therapy Disparities Diverse/Diversity Equity HCV treatment Hispanic/Latinx Liver Cancer Race/Racial Transplant aHR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" adjusted hazard ratio ARLD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" alcohol-related liver disease CI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" confidence interval DAA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" direct-acting antiviral HCC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" hepatocellular carcinoma HBV" },{" #name" :" keyword" ," $" :{" id" :" kwrd0115" }," $$" :[{" #name" :" text" ," _" :" hepatitis B virus HCV" },{" #name" :" keyword" ," $" :{" id" :" kwrd0125" }," $$" :[{" #name" :" text" ," _" :" hepatitis C virus IFN" },{" #name" :" keyword" ," $" :{" id" :" kwrd0135" }," $$" :[{" #name" :" text" ," _" :" interferon IQR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0145" }," $$" :[{" #name" :" text" ," _" :" interquartile range LT" },{" #name" :" keyword" ," $" :{" id" :" kwrd0155" }," $$" :[{" #name" :" text" ," _" :" liver transplant MELD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0165" }," $$" :[{" #name" :" text" ," _" :" Model for End-stage Liver Disease NASH" },{" #name" :" keyword" ," $" :{" id" :" kwrd0175" }," $$" :[{" #name" :" text" ," _" :" nonalcoholic steatohepatitis PAF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0185" }," $$" :[{" #name" :" text" ," _" :" population attributable fraction RBV" },{" #name" :" keyword" ," $" :{" id" :" kwrd0195" }," $$" :[{" #name" :" text" ," _" :" ribavirin UNOS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0205" }," $$" :[{" #name" :" text" ," _" :" United Network for Organ Sharing |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
